Currently, there are 821.41M common shares owned by the public and among those 816.02M shares have been available to trade.
The company’s stock has a 5-day price change of -4.97% and -4.51% over the past three months. CL shares are trading 18.83% year to date (YTD), with the 12-month market performance up to 31.94% higher. It has a 12-month low price of $72.36 and touched a high of $109.30 over the same period. CL has an average intraday trading volume of 4.24 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.75%, -7.85%, and 0.39% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Colgate-Palmolive Co. (NYSE: CL) shares accounts for 84.02% of the company’s 821.41M shares outstanding.
It has a market capitalization of $77.39B and a beta (3y monthly) value of 0.40. The stock’s trailing 12-month PE ratio is 27.21, while the earnings-per-share (ttm) stands at $3.48. The company has a PEG of 2.94 and a Quick Ratio of 0.68 with the debt-to-equity ratio at 19.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.51% over the week and 1.53% over the month.
Earnings per share for the fiscal year are expected to increase by 10.97%, and 8.04% over the next financial year. EPS should grow at an annualized rate of 9.26% over the next five years, compared to 0.18% over the past 5-year period.
Looking at the support for the CL, a number of firms have released research notes about the stock. Stifel stated their Hold rating for the stock in a research note on October 28, 2024, with the firm’s price target at $105-$101. Piper Sandler coverage for the Colgate-Palmolive Co. (CL) stock in a research note released on September 24, 2024 offered a Overweight rating with a price target of $121. Wells Fargo was of a view on September 16, 2024 that the stock is Underweight, while Deutsche Bank gave the stock Hold rating on September 09, 2024, issuing a price target of $107- $109. HSBC Securities on their part issued Hold rating on July 26, 2024.
